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Summary 
-----,A- 
The aim of the studnes described ~n this thresls wns to ~nvestlgrlte nvltrlc oxldc 
(NO)-mediated gualulosine 3',5'-cyclic ~nol~ophospl~nlte (cGMP) syrltlllesis r ~ i  
t h e  ceiitral nervous system (CNS), with respect to rts relatmon i,o Icarnlrrg 
and memory. NO-cGMP signahng is found I l a  wlrt~ially all reglonu of the 
CNS. Five protem families are  in\~c~lved in the regulat~an of tile NO-cGMP 
signaling cascade. NO synthclse (NOS) 1s responsible for the synthesus af 
NO, the endogeilous actlvataa. of the 30-receptive guanylyl cyeYase (GC), 
known as  the  sulublc lsoform of tl-tls enzyme (sGC). Binding of NO to sGG 
can lead to a huiadredfold stiimulat~on ob' cGMP synthesrs. Thc pl-oduced 
cGMP plays an nmportant role a s  a second messenger In cells and t.lreroforc. 
cGMP levels need ta  be criltically regnlated. cGM1' concen~rarioiau arc far a 
large part regulated by the activity of cGMP-hydrolyzing enzymes,  the ;3',5'- 
cycl~c nucleotide phosphadiesterases (I'UEs). Nowadays, R lot,al of 11 
dafferent PDE families have been udentlfied, consisting a f  ail eutimatcd 
ninety-five different forms. Other proternis ~n~rolved i n NO-cGM1-I signnling 
are the cGMP-dependent protein kinases and the rGlllP-regulated ion 
channels. 
The iilvolveinenlt of a number of protein families In NO-cGh1lJ signaling, 
expressed an various cell types and  brain areas. points to the involvement ol" 
this cascade in numerous brain processes. In this tl-res~e researclr was 
performed on the function of this srgnaling patl-rway in lcariving and 
memory. This was chosen for the reason that il had beell foxxnd by our 
departmerrt and olbev external research groups that inhihilion of NO 
synthesis had a n  adverse effect on learnil-tg and anernary in a nrt111her of 
animal tasks, including the object recognit,ron test.  Iln cc~t~ t l . i l s t ,  >l~)p~l~itL~011 
of a compound whlch can nnhi'blt a PIIE f:lm~ly ol'i,ype 5 (P13E6) re~ul t .1~~1 In 
aai improved perfornirnnee 111 the object recognit~on t1-rs;lc. The pi.eclt.;e 
mechan~snl  tha t  occurs after applncatron uf :I PI1135 anhrbrfor was unlznowr~ 
at the s tar t  of our  invcstlgations I t~ur t l ic r~no~e,  it, wtrs \-rot c1ea-l). w l r ~ a r ~  1"1)I!: 
ir~lllrlbitors are ttffectlve in the bra~rl .  Therefore, thc local~zaliom oi 
carnpolle~lts involved ill NO-cGMp sigilali~-tg were siudicd rn rlc~;r~l. 'r"eslung 
of 11ove1 PDE5 inhnbltors was one of  he approuchcsv usedl 111 thrs resmrch. 
Speclal ernphnsrs was given to  study the localaza~lon of 131>1<5 rn the b r a ~ ~ n  rn 
comparlsoli to other cGkll1-I-hydl-olyzirrg PDI!: farnll~cs. 
Chapter L gives a historical descrlptlon oL' t h e  drscovery of' NO-c162MlJ 
signaling and describes the dzfferont c o n ~ p o n ~ n t s  rnvolvcd rn thrv caseadw. 
The cellular targets of eGMP are discussed In detall with spccral crnphtlsid 
arz the dcscriptron and bnochernical characlernsiics of  he supcrfhm~ly of' 
PDEs. Furthermore, studies ctn eGMI' signdung r i l  relatic~n to 1car.nrng a n d  
memory models arc revi~wed.  
In Chapter 2 the effects of the in viuu application of PDE5 inhibitors such 
a s  s~ldenafil and vardeslafil un object recognition memory are dcscrlbed in 
relation to thenr administrat~on in vitro usmg hlppocampal sllces. Both 
ErUES ~ n h ~ b i t o r s  enhanced retentnun far object memory, with vardenafil 
bemg more potent t han  ..;~ldcnafil, In agreemen6 LFI uitro analysls of both 
PDES ~ n h ~ h j t o r s  confirmed thc  hlgher potency of vardenafil. Both 
eolrnpoundv induced local eGMP aceurnulalion III neuronal fibers of the 
hippocampus. at. is argued tha t  the observed eGMP accumulation in the  bn 
uilro inczubated hippocampus slice rnvght be par% of the underlyrng 
mechanism of memory improvement aRer in uilso administratron of PUE5 
inhibitors. 
Since scarce rnfcormatlon was ava~lable  about the  effects of seVecLive 
rnhrbitors of 13YE isloforms in the hnppocampus, the properties of a number 
of PUE rnh~bitors  rrn cGMP and c M P  accumulation in the hippoearnpus 
slices a re  described ~n greater detail in Chapter 3. Dose response curves 
i~11owccV a strong cCMP production after incubtrtlon of hippocampus slices 
wltl.1 Ehe non-selective PDE ~nlhibitor 3-isohutyl-1-methylxanthine (IEMX), 
the PDR2 inhibitor erythro-9-(2-11 ydroxy-3-noslyl)adenine (El-INA) and the  
rnixcd type inhlIbaLor dipyridamole. Fzartbarnnorc, it was observed u s ~ n g  
eGMP-irnsnw~~ocytachemisLry~ tha t  these ii~hibitors st;i~nulated cGMP 
accumulation throughout the hippocampal slices, whereas the  PDE5 
rnl.~ublt#or zaprinast induced a more local cCMP producticrn, similar a s  
srldenaf~l orb v a ~ d e ~ n a f ~ l  (Chapter 2). Purilherrnore, GGMP accurnzllation tn 
the hippoeainp~ls slices was yuanntified ~ l s ing  a classical radioimmunoassay 
and by semi-qut~rutitative measurements of cCbMP-imrnunof~o~~lescenco 
intcrzsity using a n  Image analysis system. Both methods yielded essential 
ideilit~cal results. However, the rrnmunocytochemical approach has  the 
additronal advantage tha t  the structures responding to the "teratnnent a re  
visible and can be characterized by doruble immunercytocherrrlstry uslng 
s l ruc tu~~a l  nd neurncl-zernical izuarlrers. 
111 Chapter 4 wc sl~adrrerl sGC a c d ~ w a f ~ o n  Lasang NO donors and the novel 
NO-zndepetrdrnt sGG sLrmul;ttars Y C-1 and  NAY 41 -2272. The objective was 
La compnrc thc  ~ e l l u l a r  Y ~ ~ W C ~ Z I ~ C S  sy~~ thes i z lng  cCM13 In three different 
Isl.t.1~11 areas wrth NCJ doi~ors of diflcrcnc clnsscs, varyirrg ~n the nneehazalsrn 
of NO rclcase. Ii was observed tha t  although the NO donors d~ffered to some 
cxlcnt 131 tllcir potency to stlnkul:~te cGMP proc2~.1cl1orr, the  cGMP-responsive 
cellular st ruct wres were snnnilnr, 1.e. mainly in \*aricose fibers. In the cortex, 
cGh1 P-trtlmitnareacl lvily was p~~edormenantly present an cl~olinevgx fibcrs 
u f  er ~ncltb~rt ian of the slices with an N O  dolaor or UC-L or BAY 181-2272? 
alone. T n  eonirast, co-adn~inrstration 11f a n  NO donor will1 YC-I  or BAY 41- 
2272 ~xterrrled cGMP slauiing to GARr\crglc and glutsurnatergrc neurons. I t  
was conclntded tha t  SCC in GXBAergac and glutamaterigxc cells appears to 
bc unrcspolzsivc? to NO ~lrrthout the presence of a NO-rndepea?dent actlval.or 
of sGC. I l~rother  explatiattnrr rllnght be tl.rat sCC i s  desensitlzcd rapldly 
andjar that the rate of cGMP breakdown in ehese cells gl.r>at.ly exceeds tlnc 
rate of cGMP synthesis induced by NO only. 
In Chapter 5, the rat  eGMP-sgcclf~c T'DE type 9 (PD1391) was ~~~vl;:stigatecl la 
closer deball. Structural analysis of the clorzcd rat PDE9 revealed tha t  this 
PDE is higl-rlv homologous to the mouse and hunr:an PUES and contains 
potential dollnavns for regulation by protern Bc~nases, uneluding cGhdE3- all$ 
CAMP-dependent protein Qr~nases. Furthermore, the cellular rnRNrl 
distribution patterns of PDES ware investigated ~n the brain. Id wras found 
that  PDISS is highly expressed mamnly in neurons throughout dl~c rat and 
mouse bi-aln, i~aclwdlng strong expression irr cerebrllum and hlppucanlpus. 
Chapter 6 describes a corrrparlsori of the mRNA locwli~atrolr ptxtter11s of 
three cCMP-hydn-olyzlng PDE families, 1.e. PDEB, PI-IE.5 and 13UF:9, during 
development of the rat brain. PDK9 was Lhe most abvrildai~lly cxpsessecl 
PDE throughout the brain, hlllowed by PDE2 and PD135. Thc cxp~*ession 
patterns of each of the  PDE families was maitlt;-~lnecl clur~ng the 
development of the brain, althouglr in some cull types PDE rxpresslon was 
absent in early stages. For I l ~ e  first time it wils deanonstrated I tiat Pn125 is 
expressed in other brnin areas besides the cerc~bell~~ln. as  had been 
described previously, arrd was present in avens such RS cortex and 
hlppocampus. The results ~r~clicate that  some cell tvpes. strcl~ :IS LEne 
hippocampal pyramidal cells and the P~l rk in je  cells in  thc ccl-ebellu~n CO- 
express the rnlZNAs of all three eCMP-degrading PDE farnllleu. 
In Chapter 7 a cornparisoil was made between the localizataon w T  NO- 
mediated cGM1' sigl~allng in the inouse and ra t  hippoean~pus. IL was fimnd 
that the localizat~on patterns of' cGMP-imialumoreacti'~,~ity d~l'fer betwecmz the 
two species. In mouse hippocampus, cGMP stn~nillg 1s predorninmntly 
present in astroeytes, whereas cCMI3 is present, lrraillny in varlcosc f'i'ibers 111 
rat  Er~ppocampal slices. To irrwrstignte I$' this rluffca~crr~:c wils d u c  to  u 
dirFerential expression of co~npoments of'cGM1' s ~ g n a l i l ~ g ,  tll-rc? loeal~zntlou of 
the beta1 subunnt of sGG ancl of J3ISIU%, P D K 5  :rnd 1'1>1<9, dlrrcc cl;M13- 
hydralyzirig PDEs, was studied 1a-r rat irlnd nnousc hi~ppoc:~n~pu..: It. wwb 
concluded that  although eGMl~-s~aanarzg pwilerrrs: diUfer brtwccrr rtr t  :mci 
mouse hrppoeampus, ltacalizatlon patterns 06' 8(:C: ilild BJJ31?2, I'lDI<!i a n d  
PDES mENAs are s~mi la r  in both ipccros. l'l-r~se dati l  polnl, i o  thnt ctlrc! 
should be taken when extrapolating rcsullts of cxper~mont,~ oI NO-cGNOIP 
signaling in d~fferenl species. 
Final coaclusions 
Admrnistration of PDE5 rnlinb~toru to rats  leads to a n  enhanced pelxfarmance 
In an object, recogn~tion task. To obtain more insight in the rnechanlsrn of 
action af PDE5 inhibitors, these ~lnh~bitors  in eomblna"tan w~t l?  inhibitors of 
other PUE Igmilles were investlgatcd u a n g  ~m u i t m  incubation of brain 
el~ces.  The method of in vrtro lnc~lbatton of slvces 1s a n  appropriate method 
l o  inwestagatc whether a compound of interest can stimulate cyclic 
nucleotide (cCM13 and CAMP] levels In the  brain and In which cellular 
structures. However, I I  can he cancluded tha t  this method does not. provide a 
strazghtforward answer Lo the  question whether the  observed naemory 
~rnprc~werment after In ~ 1 ~ 0  apiplicat~on of a PDE5 inhibitor is due to a n  
Increase in cGMP levels through I'DE5 tnhnb~tion. 'B'lals 1s because an effect 
on cGMP levels was observed a t  relative high concentrations oB" the PDE5 
~nhibl tor .  At these high inl-ubntor concentrations, other proteins such a s  
other mcrnbers of t he  PDE famlly will po~slbly be inhibited in addition to 
PD155. Since the final concentration of a PDE5 inhlblrtnr in the  brarml, or 
~ntracel lular  1s not kllovlrn afier tn rltuo ad~mnrlstratlon, a direct correlation 
between the in  uilro and in VLVO data 1s diffic~llt. This situataon is even more 
complex as we also have to take  into account t h e  expressnan of multiple 
~rnembers of various 1)14E families 1n One cell type, a n a o r  cellular 
con~parl rnenl, and  the cllffcretltlal regulation af each PDE family by events 
slxch as phosphorylation, and  reg~rlation by cG%W and/or c!!JvfP. 
Nevertheless, the observed memory enhancing effect by P D M  inh~bl tors  
holds promnse for f ~ n t ~ ~ r e  therapeutic use a s  cognltlon enhancers and, ~t 
should therefore be vnvestigated whether these compounds can also improve 
cognitive pel-ibrmance in humans.  
Samenvatting 
Het doel vaai de studies beschreven zn dll proefscl~islft wns een oi~dcrzocic t~ 
uerrichteit aan  de stikscoi monoxide. (NO)-gestiinullee~+dt giiRnosiilc 3".5'-  
cyclic izionophospliate (cGMP) vorming i11 de he'sei~eiii. in relatie tot. lertc~i cAn 
ge1zeuger.r. NO-geinducearde cGMP prodi~ctlc wordt nrungetroffeii dooi* 1aet 
gehele brein. Een vigftal families t7i-i11 elwitten speelt een behatlgr~jke 1'01 bij 
de regulatie van het NO-cGMP signaaloverdrachL systeem. E0 synitliase 
(NOS) zorgt lioor de vorming van NO, dat, ver~*olgcns liet enzyni gcilaamd 
oplosbaar guariiylyl eyclase i(sGC)i kan activeren tot de vormiing vali cGh4P. 
Binding van NO aan  het.. sCC kan lelden tot een honderd\rotidige stiriiulat.ie 
van de cGMP pl-oductie. Hel  gevormde cGMP speelt een belangrijke rol als 
een boodschapper molecuul in cellen eii daaroili moeten cGMP nlvpnus 
intracellulair sterk gereguleerd warden. cGMB gelzalten won.dcii voor cen 
groot gedeelte bepaald door de  activiteit van cGMP-ailirekerrdr erixyateti, dc 
zogelzeten 3"s'-cyclic nucleotide fosfod~iesterases (PDEc). Op dit iizorncnt 
zijn elf vcnscliillende IJDE families geiclentif~ceerd. waarbij liet totale italnt,al 
verschillende varrilen binnen deze famille gc~cl ia t  wordt up v i~ f~nnegr i r t~g .  
Daarrraast zijn bij de cGMP slg~zaalioverdraeht nog andere f~~miliies 
betrokken, waaronder de cGMP-afiankelijke proterne kmasen en  de cGMP- 
gereguleerde iankanaleìz. 
Het  feit dat, versclrillel-ide eiwitlarnuhes X~ctraklreil zijn bij NO-cC;M13 
slgnaaloverdracht die tot expressie gebracht worden in vcrcchillcnde 
celtypen en Enersengebieden, wqst erop dat  dil, signaixloverdrachZ. syst.ecina 
Inetrokkei~ rs I s i ~  een groot aantal hersenfuncties. Ini dit proefs~l-i~if'l werd 
onderzoek gedaan naa r  de rol van NO-cGMI-' s~gi~aalro~nt,c rn Jlcrcri en 
gehettgen. 13e reden hiervoor was d a ~  ccrrleru' stiidies cloc-ui. tlc viikgr*ni:p c11 
exierne onderzoelisgroepm haddcri n:rngekoond dal I-eniirnilig van dc NO 
vorïniz~g een negatief effect heeft op J e r ~ n  ei1 gclieugenz talieti i12 <?ei? ;~:rnt:ll 
die~.soorteiz. In tegeiistellrng, toediening van cc?n stol' drc hel type 6 v:111 CIC 
PDE fammlie (P1:iES) kan reiamen. een PDH5 i*enlia-rein. resultcertlc 113 c:cn 
verbetering van dc prestatnc i17 een geheugentank bij ratteri. ~ll;dl31(?l i1~l i  I M  di: 
object herkenniilgstaak. I-Iet wcrklngsmec:han~siiic dat  opli.ccdt I ~ E I  
toediening van een PUI35 reminer was onbekc~acl tijdetas dc start vílitl hel, rn 
dit proefschrift beschreven onderzocksproject. Ook was het cirrduitlc?li~li ~ / : u ; - ~ i .  
PDE remmers In de hersenen h u n  effcct wltoefe~~cn. Dn:lrorn ~ ' c r d  de 
lokalisatie van eornponenlen bctroklten bq NO-eGMP sign;.ialoverdr':ir:ht 
nader bestudeerd. Hiervoor werd ondcrrneer gcbrulli; gcaniaakt V:III laet 
testen van nicuw ontwikkelde PIIE5 remmers. Sp~cinlc  aamdacht mcrd 
gegeven aan  het  bestuderen van de lokalisatie van P13FX 117 aii~~hiruatic rnct 
verscheldene andere cGhlP-afbrekende 1-'13iE Ianrni lies. 
